Target intelligence / Profile preview

Ribosomal protein L10 pseudogene 9 (RPL10P9)

Target: RPL10P9
Molecular classification: Other (Pseudogene; it is a non-coding genomic DNA sequence similar to the functional ribosomal protein L10 gene but does not code for a functional protein[5].)

Overview

Ribosomal protein L10 pseudogene 9 (RPL10P9) is a **pseudogene** in the human genome that resembles the protein-coding gene ribosomal protein L10 (RPL10)[5][7]. Pseudogenes arise from gene duplication or retrotransposition events but have lost their ability to code for a functional protein. RPL10P9 does not encode any protein product and has no reported biological activity or direct involvement in human disease or therapy. Its parent gene, RPL10, codes for a structural component of the 60S ribosomal subunit, but RPL10P9 itself is non-functional[5][6]. Ribosomal protein L10 pseudogene 9 (RPL10P9) is a non-coding pseudogene and not a functional molecular target. It is not involved in biological processes, disease, or therapeutic targeting; thus, it is not considered a drug target and has no alias of clinical significance[5][7].

Other names: RPL10_1_637RPL10P9Ribosomal protein L10 pseudogene 9

Mechanism of action

None applicable for drugs, as it is not a drug target[5].

Biological functions

None (as a pseudogene, it is not translated into functional protein and typically has no biological function[5].)

Disease associations

None known (as a pseudogene, no direct disease association; parent gene RPL10 is associated with some disorders, but not RPL10P9[5][6].)

Safety considerations

None (no therapeutic targeting, so no safety/therapeutic concerns[5].)

Interacting drugs

None (no known drugs interact with this pseudogene[5].)

Biomarkers

None (no established role as a biomarker[5].)

Beyond the preview

Go deeper on Ribosomal protein L10 pseudogene 9 (RPL10P9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L10 pseudogene 9 (RPL10P9).

Explore the full profile